Virta Health Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
406

- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$133M
- Investors
-
33
Virta Health General Information
Description
Developer of novel treatments intended to reverse type 2 diabetes without the use of medications or surgery. The company combines advanced biochemistry and clinical expertise with data science and digital tools to develop therapies and provide physicians and health coaches to deliver on-demand care, helping people lower blood sugar and lose weight, even while eliminating the need for medications, including insulin.
Contact Information
Website
www.virtahealth.com
Formerly Known As
KetoThrive
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare Technology Systems
Other Healthcare Services
Primary Office
- 501 Folsom Street
- San Francisco, CA 94105
- United States
+1 (844) 000-0000
Virta Health Timeline
Virta Health Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC (Series E) | 19-Apr-2021 | $133M | 00000 | 00.000 | Completed | Generating Revenue |
7. Later Stage VC (Series D) | 02-Dec-2020 | 000.00 | 00000 | 00.000 | Completed | Generating Revenue |
6. Debt - PPP | 15-Apr-2020 | 00.000 | 00000 | Completed | Generating Revenue | |
5. Later Stage VC (Series C) | 10-Jan-2020 | 000.00 | 00000 | 00000 | Completed | Generating Revenue |
4. Early Stage VC (Series B) | 04-Apr-2018 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
3. Early Stage VC (Series A) | 19-Jul-2016 | 000.00 | 000.00 | 00000 | Completed | Startup |
2. Secondary Transaction - Private | 10-Jun-2014 | Completed | Startup | |||
1. Seed Round | Completed | Startup |
Virta Health Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series E | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 0.000 |
Series D1 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series D | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series C1 | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A1 | 29,270,458 | $0.000100 | $0.02 | $0.26 | $0.26 | 1x | $0.26 | 4.25% |
Series A | 62,846,938 | $0.000100 | $0.03 | $0.37 | $0.37 | 1x | $0.37 | 9.13% |
Virta Health Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel treatments intended to reverse type 2 diabetes without the use of medications or surgery. The company
Clinics/Outpatient Services
San Francisco, CA
406
As of 2022
00000
0.000
0000-00-00
00000000000
00000
Virta Health Competitors (16)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Oviva | Venture Capital-Backed | London, United Kingdom | 000 | 00000 | 00000000000 | 00000 |
0000000 | Venture Capital-Backed | Columbia, MD | 000 | 000.00 | 000000000 - | 000.00 |
000 000000 | Venture Capital-Backed | San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
00000 | Venture Capital-Backed | San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
0000 000000 | Venture Capital-Backed | San Francisco, CA | 000 | 00000 | 00000000000 | 00000 |
Virta Health Patents
Virta Health Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-10319477-B1 | Dynamic data-driven biological state analysis | Active | 08-Mar-2017 | 000000000 | 0 |
US-20190295723-A1 | Dynamic data-driven biological state analysis | Pending | 08-Mar-2017 | 000000000 | |
US-20180180633-A1 | Methods of rationally designing a personalized nutritional plan | Pending | 23-Dec-2016 | G01N33/92 |
Virta Health Executive Team (12)
Virta Health Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Donald Berwick MD | Self | Board Member | 000 0000 |
Gregory Waldorf | Self | Board Member | 000 0000 |
Robert Kocher MD | Venrock | Board Member | 000 0000 |
Sami Inkinen | Virta Health | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Stephen Phinney Ph.D | Virta Health | Co-Founder, Chief Innovation Officer & Board Member | 000 0000 |
Virta Health Signals
Virta Health Investors (33)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
75 & Sunny | Venture Capital | Minority | 000 0000 | 000000 0 | |
Chamaeleon | Venture Capital | Minority | 000 0000 | 000000 0 | |
Old Well Partners | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Summit Peak Investments | Venture Capital | Minority | 000 0000 | 000000 0 | |
Tiger Global Management | Growth/Expansion | Minority | 000 0000 | 000000 0 |